Although FABP2 chaperonopathy is not firmly established as a carcinogenic factor in patients with colon cancer and hyperinsulinemia and obesity, this issue deserves further investigation, considering the possibility of applying chaperonotherapy to treat these very sick patients. The gene discussed is FABP2; the disease is obesity disorder.